Is Annovis Bio Inc (ANVS) overvalued? · $80.4M cap
Annovis Bio Inc (ANVS) is a biotechnology company listed on US.
This page asks whether Annovis Bio Inc (ANVS) looks expensive on cached numbers — not a short thesis.
Latest reported ANVS revenue for 2024-12-31 was $0. Net income was -$24.6M. ANVS currently screens at market cap $80.4M.
ANVS currently screens at market cap $80.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ANVS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ANVS stock page for the full model, not this heading.
Not investment advice.